IMPACT OF THERAPY ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (ACCORDING TO THE RENAISSANCE REGISTER)

Objective: to assess changes in health-related quality of life (HRQoL) in patients with systemic lupus erythematosus (SLE) during performed therapy.Subjects and methods. The investigation included 128 patients with reliable SLE who fulfilled the 2012 SLICC criteria. Sixty-eight patients received sta...

Full description

Saved in:
Bibliographic Details
Main Authors: L. D. Vorobyeva, E. A. Aseeva, S. K. Solovyev, G. M. Koilubaeva, S. I. Glukhova
Format: Article
Language:Russian
Published: IMA PRESS LLC 2019-09-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/2754
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849687938228551680
author L. D. Vorobyeva
E. A. Aseeva
S. K. Solovyev
G. M. Koilubaeva
S. I. Glukhova
author_facet L. D. Vorobyeva
E. A. Aseeva
S. K. Solovyev
G. M. Koilubaeva
S. I. Glukhova
author_sort L. D. Vorobyeva
collection DOAJ
description Objective: to assess changes in health-related quality of life (HRQoL) in patients with systemic lupus erythematosus (SLE) during performed therapy.Subjects and methods. The investigation included 128 patients with reliable SLE who fulfilled the 2012 SLICC criteria. Sixty-eight patients received standard therapy; 60 used biological agents (BA). During the first visit and at 12 months, all the patients were assessed for disease activity using by SLEDAI-2K and for organ damage employing the SLICC damage index (DI). HRQoL was assessed by the LupusQoL questionnaire that was filled out by the patients independently.Results and discussion. At Visit 1, the disease activity index averaged 8.0±7.3 in the standard therapy group and 15.4±7.6 in the BA group (p≤0.001); DI was 1.2±0.9 and 1.8±1.8, respectively (p=0.008). BA-treated patients had significantly lower HRQoL scores on all questionnaire scales, except «dependence on others» and «emotional health» ones Both the standard therapy and BA groups showed significantly lower disease activity during Visit 2 at 12 months. HRQoL assessment revealed significant improvements in the scales «pain», «planning», «intimate relationships», «emotional health», «body image», and «fatigue» in the BA group. The standard therapy group had a statistically significant improvement in the scale «dependence on others». All the other scales of the questionnaire displayed a positive change in HRQoL; however, it did not reach statistical significance.
format Article
id doaj-art-2bdab672001c44e5a4a785204955b5ca
institution DOAJ
issn 1995-4484
1995-4492
language Russian
publishDate 2019-09-01
publisher IMA PRESS LLC
record_format Article
series Научно-практическая ревматология
spelling doaj-art-2bdab672001c44e5a4a785204955b5ca2025-08-20T03:22:12ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922019-09-0157442142510.14412/1995-4484-2019-421-4252513IMPACT OF THERAPY ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (ACCORDING TO THE RENAISSANCE REGISTER)L. D. Vorobyeva0E. A. Aseeva1S. K. Solovyev2G. M. Koilubaeva3S. I. Glukhova4V.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyAcademician M. Mirrakhimov National Center for Cardiology and TherapyV.A. Nasonova Research Institute of RheumatologyObjective: to assess changes in health-related quality of life (HRQoL) in patients with systemic lupus erythematosus (SLE) during performed therapy.Subjects and methods. The investigation included 128 patients with reliable SLE who fulfilled the 2012 SLICC criteria. Sixty-eight patients received standard therapy; 60 used biological agents (BA). During the first visit and at 12 months, all the patients were assessed for disease activity using by SLEDAI-2K and for organ damage employing the SLICC damage index (DI). HRQoL was assessed by the LupusQoL questionnaire that was filled out by the patients independently.Results and discussion. At Visit 1, the disease activity index averaged 8.0±7.3 in the standard therapy group and 15.4±7.6 in the BA group (p≤0.001); DI was 1.2±0.9 and 1.8±1.8, respectively (p=0.008). BA-treated patients had significantly lower HRQoL scores on all questionnaire scales, except «dependence on others» and «emotional health» ones Both the standard therapy and BA groups showed significantly lower disease activity during Visit 2 at 12 months. HRQoL assessment revealed significant improvements in the scales «pain», «planning», «intimate relationships», «emotional health», «body image», and «fatigue» in the BA group. The standard therapy group had a statistically significant improvement in the scale «dependence on others». All the other scales of the questionnaire displayed a positive change in HRQoL; however, it did not reach statistical significance.https://rsp.mediar-press.net/rsp/article/view/2754systemic lupus erythematosushealth-related quality of lifelupusqol
spellingShingle L. D. Vorobyeva
E. A. Aseeva
S. K. Solovyev
G. M. Koilubaeva
S. I. Glukhova
IMPACT OF THERAPY ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (ACCORDING TO THE RENAISSANCE REGISTER)
Научно-практическая ревматология
systemic lupus erythematosus
health-related quality of life
lupusqol
title IMPACT OF THERAPY ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (ACCORDING TO THE RENAISSANCE REGISTER)
title_full IMPACT OF THERAPY ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (ACCORDING TO THE RENAISSANCE REGISTER)
title_fullStr IMPACT OF THERAPY ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (ACCORDING TO THE RENAISSANCE REGISTER)
title_full_unstemmed IMPACT OF THERAPY ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (ACCORDING TO THE RENAISSANCE REGISTER)
title_short IMPACT OF THERAPY ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (ACCORDING TO THE RENAISSANCE REGISTER)
title_sort impact of therapy on health related quality of life in patients with systemic lupus erythematosus according to the renaissance register
topic systemic lupus erythematosus
health-related quality of life
lupusqol
url https://rsp.mediar-press.net/rsp/article/view/2754
work_keys_str_mv AT ldvorobyeva impactoftherapyonhealthrelatedqualityoflifeinpatientswithsystemiclupuserythematosusaccordingtotherenaissanceregister
AT eaaseeva impactoftherapyonhealthrelatedqualityoflifeinpatientswithsystemiclupuserythematosusaccordingtotherenaissanceregister
AT sksolovyev impactoftherapyonhealthrelatedqualityoflifeinpatientswithsystemiclupuserythematosusaccordingtotherenaissanceregister
AT gmkoilubaeva impactoftherapyonhealthrelatedqualityoflifeinpatientswithsystemiclupuserythematosusaccordingtotherenaissanceregister
AT siglukhova impactoftherapyonhealthrelatedqualityoflifeinpatientswithsystemiclupuserythematosusaccordingtotherenaissanceregister